Literature DB >> 11000024

A-Type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli.

L Y Foo1, Y Lu, A B Howell, N Vorsa.   

Abstract

Three proanthocyanidin trimers possessing A-type interflavanoid linkages, epicatechin-(4beta-->6)-epicatechin-(4beta-->8, 2beta-->O-->7)-epicatechin (4), epicatechin-(4beta-->8, 2beta-->O-->7)-epicatechin-(4beta-->8)-epicatechin (5), and epicatechin-(4beta-->8)-epicatechin-(4beta-->8, 2beta-->O-->7)-epicatechin (6), were isolated from the ripe fruits of Vaccinium macrocarpon (cranberry) and prevented adherence of P-fimbriated Escherichia coli isolates from the urinary tract to cellular surfaces containing alpha-Gal(1-->4)beta-Gal receptor sequences similar to those on uroepithelial cells. The structure of 4 was elucidated by a combination of spectroscopic methods and acid-catalyzed degradation with phloroglucinol. Also isolated were the weakly active epicatechin-(4beta-->8, 2beta-->O-->7)-epicatechin (procyanidin A2) (3) and the inactive monomer epicatechin (1) and the inactive dimer epicatechin-(4beta-->8)-epicatechin (procyanidin B2) (2).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11000024     DOI: 10.1021/np000128u

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  82 in total

1.  Inhibition of secreted phospholipase A2 by proanthocyanidins: a comparative enzymological and in silico modeling study.

Authors:  Joshua D Lambert; Neela Yennawar; Yeyi Gu; Ryan J Elias
Journal:  J Agric Food Chem       Date:  2012-07-18       Impact factor: 5.279

2.  Tri- and Tetrameric Proanthocyanidins with Dentin Bioactivities from Pinus massoniana.

Authors:  Bin Zhou; Yvette Alania; Mariana Reis; Rasika S Phansalkar; Joo-Won Nam; James B McAlpine; Shao-Nong Chen; Ana K Bedran-Russo; Guido F Pauli
Journal:  J Org Chem       Date:  2020-06-17       Impact factor: 4.354

3.  MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention.

Authors:  Laura A Kresty; Jennifer Clarke; Kristin Ezell; Amy Exum; Amy B Howell; Toumy Guettouche
Journal:  J Carcinog       Date:  2011-12-22

4.  Anti-Porphyromonas gingivalis and anti-inflammatory activities of A-type cranberry proanthocyanidins.

Authors:  Vu Dang La; Amy B Howell; Daniel Grenier
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

5.  Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double-blind randomized placebo-controlled cross-over trial.

Authors:  P Di Martino; R Agniel; K David; C Templer; J L Gaillard; P Denys; H Botto
Journal:  World J Urol       Date:  2006-01-06       Impact factor: 4.226

6.  Coumaroyl iridoids and a depside from cranberry (Vaccinium macrocarpon).

Authors:  Allison Turner; Shao-Nong Chen; Dejan Nikolic; Richard van Breemen; Norman R Farnsworth; Guido F Pauli
Journal:  J Nat Prod       Date:  2007-02-02       Impact factor: 4.050

7.  The effect of OPC Factor on energy levels in healthy adults ages 45-65: a phase IIb randomized controlled trial.

Authors:  Patrick J LaRiccia; John T Farrar; Mary D Sammel; Joseph J Gallo
Journal:  J Altern Complement Med       Date:  2008-07       Impact factor: 2.579

8.  Cranberry proanthocyanidins are cytotoxic to human cancer cells and sensitize platinum-resistant ovarian cancer cells to paraplatin.

Authors:  Ajay P Singh; Rakesh K Singh; Kyu Kwang Kim; K S Satyan; Roger Nussbaum; Monica Torres; Laurent Brard; Nicholi Vorsa
Journal:  Phytother Res       Date:  2009-08       Impact factor: 5.878

9.  Expression, modulation, and clinical correlates of the autophagy protein Beclin-1 in esophageal adenocarcinoma.

Authors:  Katherine M Weh; Amy B Howell; Laura A Kresty
Journal:  Mol Carcinog       Date:  2015-11-19       Impact factor: 4.784

Review 10.  Cranberry and urinary tract infections.

Authors:  David R P Guay
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.